Discontinuation of Statins: What Are the Risks? (Q38843485)

6 September 2017

1 reference

title

Discontinuation of Statins: What Are the Risks? (English)

1 reference

6 September 2017

Joel C Marrs

1

1 reference

PubMed ID

27221503

6 September 2017

Matthew D Kostoff

series ordinal

2

1 reference

6 September 2017

1 July 2016

1 reference

Current Atherosclerosis Reports

6 September 2017

1 reference

6 September 2017

18

1 reference

6 September 2017

41

1 reference

6 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-016-0596-z

6 September 2017

0 references

cites work

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Continuation of statin treatment and all-cause mortality: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

An assessment by the Statin Muscle Safety Task Force: 2014 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

An assessment by the Statin Liver Safety Task Force: 2014 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Comparative efficacy and adverse effects of the addition of ezetimibe to statin versus statin titration in chronic kidney disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Statin therapy and risks for death and hospitalization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Statins and mortality among elderly patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Evaluation and treatment of older patients with hypercholesterolemia: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Statin use and clinical outcomes in older men: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Cholesterol, statins, and longevity from age 70 to 90 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Patients who discontinued statin treatment: a protocol for cohort study using primary care data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-016-0596-Z

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27221503

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥ 80 years of age: observations from the CREDO-Kyoto Registry Cohort-2

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27221503

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27221503

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11883-016-0596-Z

1 reference

PubMed ID

27221503

Dimensions Publication ID

6 September 2017

0 references

1 reference

PubMed ID

27221503